المؤلفون: Anonymous

المصدر: Information från Läkemedelsverket. 30(3):45

المؤلفون: H.J. Longhurst, Anette Bygum, Teresa Caballero, Marcus Maurer, Laurence Bouillet, Anete Sevciovic Grumach, Irmgard Andresen, Werner Aberer, Jaco Botha, Andrea Zanichelli

المساهمون: Maurer, M [0000-0002-4121-481X], Grumach, AS [0000-0002-9803-0309], Apollo - University of Cambridge Repository, Publica

المصدر: Maurer, M, Caballero, T, Aberer, W, Zanichelli, A, Bouillet, L, Bygum, A, Grumach, A S, Botha, J, Andresen, I, Longhurst, H J & for the IOS Study Group 2021, ' Variability of disease activity in patients with hereditary angioedema type 1/2 : longitudinal data from the Icatibant Outcome Survey ', Journal of The European Academy of Dermatology and Venereology, vol. 35, no. 12, pp. 2421-2430 . https://doi.org/10.1111/jdv.17654Test

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Dermatology, Disease, Angioedemas, Hereditary/drug therapy, Bradykinin, Disease activity, chemistry.chemical_compound, Icatibant, Bradykinin/analogs & derivatives, Humans, Medicine, In patient, Retrospective Studies, Hereditary Angioedema Types I and II, Angioedema, business.industry, Angioedemas, Hereditary, Retrospective cohort study, medicine.disease, Treatment Outcome, Infectious Diseases, chemistry, hereditary angioedema type 1/2, Hereditary angioedema, Icatibant Outcome Survey, Observational study, medicine.symptom, business, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit

وصف الملف: text/xml; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::114c0e42534209b51f6a16d61d62884dTest
https://doi.org/10.1111/jdv.17654Test

المؤلفون: Perković, Dijana, Barešić, Marko, Ražov Radas, Melanija, Jureković, Irena, Novak, Srđan, Anić, Branimir, Karadža Lapić, Ljerka, Prus, Višnja, Stipić Marković, Asja

المصدر: Liječnički vjesnik
Volume 144
Issue 11-12

مصطلحات موضوعية: HEREDITARNI ANGIOEDEM – farmakoterapja, prevencija, C1 INHIBITOR ESTERAZE – terapijska uporaba, HUMANIZIRANA MONOKLONSKA PROTUTIJELA – terapijska uporaba, KALIKREIN U PLAZMI – antagonisti i inhibitori, DANAZOL – terapijska uporaba, BRADIKININ, ANGIOEDEMAS, HEREDITARY – drug therapy, prevention and control, COMPLEMENT C1 INHIBITOR PROTEIN – therapeutic use, ANTIBODIES, MONOCLONAL, HUMANIZED – therapeutic use, PLASMA KALLIKREIN – antagonists and inhibitors, DANAZOL – therapeutic use, BRADYKININ, Deskriptori HEREDITARNI ANGIOEDEM – farmakoterapja, prevencija

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4267a5ec3d794b2c1d8fdf83bbf4f7e1Test
https://hrcak.srce.hr/289200Test

المؤلفون: Åbom, Anne Louise Nörmölle, Palarasah, Yaseelan, Bygum, Anette

المصدر: Ugeskrift for Laeger. 174(34):1894

المؤلفون: Platzer, Rita

المصدر: Medicinsk Access. 6(7):19

المؤلفون: Stehlin, F., Ribi, C.

المصدر: Revue medicale suisse, vol. 16, no. 689, pp. 675-678

مصطلحات موضوعية: Angioedema, Angioedemas, Hereditary/drug therapy, Angioedemas, Hereditary/enzymology, Antibodies, Monoclonal, Bradykinin/analogs & derivatives, Bradykinin/therapeutic use, Complement C1 Inhibitor Protein/therapeutic use, Complement Inactivating Agents/therapeutic use, Esterases/antagonists & inhibitors, Humans

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1900::abf356d09986d8966101d575b62cebd5Test
https://serval.unil.ch/notice/serval:BIB_5093AD198998Test

المؤلفون: Anette Bygum, Oda Jordal

المصدر: BMJ Case Rep
Jordal, O & Bygum, A 2019, ' New approach in prophylactic treatment of a challenged HAE patient ', BMJ Case Reports, vol. 12, no. 3, e227061 . https://doi.org/10.1136/bcr-2018-227061Test

مصطلحات موضوعية: Adult, 0301 basic medicine, medicine.medical_specialty, Self Administration, Angioedemas, Hereditary/drug therapy, Very frequent, 03 medical and health sciences, 0302 clinical medicine, Patient Education as Topic, Quality of life, medicine, Humans, Severe pain, Complement Inactivating Agents/pharmacology, Intensive care medicine, Novel Treatment (New Drug/Intervention, Established Drug/Procedure in New Situation), Complement C1 Inhibitor Protein/pharmacology, business.industry, Angioedemas, Hereditary, Off-Label Use, General Medicine, Traditional therapy, medicine.disease, Complement Inactivating Agents, Treatment Outcome, 030104 developmental biology, 030228 respiratory system, Hereditary angioedema, Quality of Life, Female, business, Complement C1 Inhibitor Protein, Prophylactic treatment

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::537a28ceddae2e435313739e803a1006Test
https://doi.org/10.1136/bcr-2018-227061Test

المؤلفون: De Rojas, Dolores Hernández Fernandez, Ibañez, Ethel, Longhurst, Hilary, Maurer, Marcus, Fabien, Vincent, Aberer, Werner, Bouillet, Laurence, Zanichelli, Andrea, Caballero, Teresa, MARONE, GIANNI

المساهمون: De Rojas, Dolores Hernández Fernandez, Ibañez, Ethel, Longhurst, Hilary, Maurer, Marcu, Fabien, Vincent, Aberer, Werner, Bouillet, Laurence, Zanichelli, Andrea, Caballero, Teresa, Marone, Gianni

المصدر: Hernández Fernandez de Rojas, D, Ibañez, E, Longhurst, H, Maurer, M, Fabien, V, Aberer, W, Bouillet, L, Zanichelli, A, Caballero, T, IOS Study Group & Bygum, A 2015, ' Treatment of HAE Attacks in the Icatibant Outcome Survey : An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals ', International Archives of Allergy and Immunology, vol. 167, no. 1, pp. 21-28 . https://doi.org/10.1159/000430864Test

مصطلحات موضوعية: Male, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage, Self Administration, chemistry.chemical_compound, Icatibant, Retrospective Studie, Health care, Bradykinin B2 Receptor Antagonists, Immunology and Allergy, Prospective Studies, Young adult, Prospective cohort study, Data Collection, Medicine (all), Anti-Inflammatory Agents, Non-Steroidal, food and beverages, Bradykinin/administration & dosage, Self-administration, General Medicine, Middle Aged, Treatment Outcome, Anesthesia, Female, Self Administration/adverse effects, Human, Adult, medicine.medical_specialty, Adolescent, Immunology, Bradykinin, Angioedemas, Hereditary/drug therapy, Bradykinin B2 receptor antagonist, Young Adult, Internal medicine, medicine, Humans, Retrospective Studies, Aged, business.industry, fungi, Angioedemas, Hereditary, Retrospective cohort study, Clinical trial, Oedema, Prospective Studie, chemistry, Hereditary angio-oedema, Icatibant Outcome Survey, Bradykinin B2 Receptor Antagonists/administration & dosage, C1 inhibitor deficiency, Therapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec643d743aadb4504922a2973f8c40aTest
http://hdl.handle.net/11588/636186Test

عناروين إضافية: Long-term prophylaxis of hereditary angioedema

المصدر: Liječnički vjesnik; ISSN 0024-3477 (Print); ISSN 1849-2177 (Online); Volume 144; Issue 11-12

مصطلحات الفهرس: Deskriptori HEREDITARNI ANGIOEDEM – farmakoterapja, prevencija; C1 INHIBITOR ESTERAZE – terapijska uporaba; HUMANIZIRANA MONOKLONSKA PROTUTIJELA – terapijska uporaba; KALIKREIN U PLAZMI – antagonisti i inhibitori; DANAZOL – terapijska uporaba; BRADIKININ, ANGIOEDEMAS, HEREDITARY – drug therapy, prevention and control; COMPLEMENT C1 INHIBITOR PROTEIN – therapeutic use; ANTIBODIES, MONOCLONAL, HUMANIZED – therapeutic use; PLASMA KALLIKREIN – antagonists and inhibitors; DANAZOL – therapeutic use; BRADYKININ, text, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://hrcak.srce.hr/289200Test
https://hrcak.srce.hr/file/425070Test
info:eu-repo/semantics/altIdentifier/doi/10.26800/LV-144-11-12-9